1. Home
  2. SPRY vs TY Comparison

SPRY vs TY Comparison

Compare SPRY & TY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • TY
  • Stock Information
  • Founded
  • SPRY 2015
  • TY 1929
  • Country
  • SPRY United States
  • TY United States
  • Employees
  • SPRY N/A
  • TY N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • TY Finance Companies
  • Sector
  • SPRY Health Care
  • TY Finance
  • Exchange
  • SPRY Nasdaq
  • TY Nasdaq
  • Market Cap
  • SPRY 1.6B
  • TY 1.6B
  • IPO Year
  • SPRY N/A
  • TY N/A
  • Fundamental
  • Price
  • SPRY $17.69
  • TY $32.00
  • Analyst Decision
  • SPRY Strong Buy
  • TY
  • Analyst Count
  • SPRY 4
  • TY 0
  • Target Price
  • SPRY $28.75
  • TY N/A
  • AVG Volume (30 Days)
  • SPRY 1.6M
  • TY 43.0K
  • Earning Date
  • SPRY 08-05-2025
  • TY 01-01-0001
  • Dividend Yield
  • SPRY N/A
  • TY 3.36%
  • EPS Growth
  • SPRY N/A
  • TY N/A
  • EPS
  • SPRY N/A
  • TY 4.78
  • Revenue
  • SPRY $97,122,000.00
  • TY N/A
  • Revenue This Year
  • SPRY N/A
  • TY N/A
  • Revenue Next Year
  • SPRY $170.64
  • TY N/A
  • P/E Ratio
  • SPRY N/A
  • TY $6.38
  • Revenue Growth
  • SPRY 971120.00
  • TY N/A
  • 52 Week Low
  • SPRY $8.91
  • TY $25.16
  • 52 Week High
  • SPRY $18.90
  • TY $30.73
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 60.97
  • TY 64.37
  • Support Level
  • SPRY $16.40
  • TY $31.59
  • Resistance Level
  • SPRY $18.05
  • TY $32.14
  • Average True Range (ATR)
  • SPRY 1.06
  • TY 0.39
  • MACD
  • SPRY 0.03
  • TY 0.04
  • Stochastic Oscillator
  • SPRY 62.54
  • TY 91.25

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About TY Tri Continental Corporation

Tri-Continental Corp is a United States-based closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.

Share on Social Networks: